Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II

BACKGROUND: Anastrozole reduces breast cancer risk in women at high risk, but implementing preventive therapy in clinical practice is difficult. Here, we evaluate adherence to anastrozole in the International Breast Cancer Intervention Study (IBIS)-II prevention and ductal carcinoma in situ (DCIS) t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sestak, I, Smith, S G, Howell, A, Forbes, J F, Cuzick, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834118/
https://www.ncbi.nlm.nih.gov/pubmed/29126161
http://dx.doi.org/10.1093/annonc/mdx713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834118/
https://www.ncbi.nlm.nih.gov/pubmed/29126161
http://dx.doi.org/10.1093/annonc/mdx713

Ejemplares similares